Hennig, R.; Borowiak, M.; Ruhaak, L. R.; Wuhrer, M.; Rapp, E.: High-Throughput CGE-LIF Based Analysis of APTS-labeled N-Glycans, Utilizing a Multiplex Capillary DNA Sequencer. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 331. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Hennig, R.; Reichl, U.; Rapp, E.: A Software Tool for Automated High-Throughput Processing of CGE-LIF Based Glycoanalysis Data, Generated by a Multiplexing Capillary DNA Sequencer. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 331. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Hütter, J.; Rödig, J.; Reichl, U.; Seeberger, P. H.; Rapp, E.; Lepenies, B.: Impact of Influenza A virus hemagglutinin N-glycosylation on immunogenicity. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 305. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Janke, R.; Genzel, Y.; Wetzel, M.; Reichl, U.: Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. In BMC Proceedings, 5 (S8 ), P129. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)

Kolarich, D.; Rapp, E.; Packer, N.: Bioinformatics in Glycoproteomics – Challenges, Frontiers and Solutions. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 251. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Kottler, R.; Hennig, R.; Mank, M.; Stahl, B.; Reichl, U.; Rapp, E.: High-Throughput Characterization of the Human Milk Oligosaccharide Composition Utilizing a Multiplexing Capillary DNA Sequencer. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 330. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Rapp, E.; Hennig, R.; Borowiak, M.; Kottler, R.; Reichl, U.: High-Throughput Glycosylation Pattern Analysis of Glycoproteins Utilizing a Multiplexing Capillary-DNA-Sequencer. In Glycoconjugate Journal, 28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), p. 234. 21st International Symposium on Glycoconjugates - Glyco 21, Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)

Roedig, J.; Rapp, E.; Genzel, Y.; Reichl, U.: Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, 5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)

Scholz, S.; Luebbecke, M.; Rath, A.; Schraeder, E.; Rose, T.; Büntemeyer, H.; Scheper, T.; Reichl, U.; Noll, T.: Characterization of the human AGE1.HN cell line: a systems biology approach. In BMC Proceedings, 5 (S8 ), P78. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)

Schräder, E.; Scholz, S.; Niklas, J.; Rath, A.; Barradas, O.P.; Jandt, U.; Sandig, V.; Rose, T.; Pörtner, R.; Reichl, U. et al.; Zeng, A.P.; Heinzle, E.; Noll, T.: Characterisation of cultivation of the human cell line AGE1.HN.AAT. In BMC Proceedings, 5 (S8), P87. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)

Kuhn, R.; Benndorf, D.; Rapp, E.; Reichl, U.; Pollice, A.; Palese, L.: Metaproteomanalyse von Klärschlamm aus Membranbioreaktoren. In Chemie Ingenieur Technik, 82 (9 - Special Issue: ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), pp. 1539 - 1540 . Processet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. Verlag Chemie, GmbH, Weinheim, Germany (2010)

Vester, D.; Rapp, E.; Kluge, S.; Genzel, Y.; Reichl, U.: Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), p. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. (2010)

Öncül, A.; Kalmbach, A.; Genzel, Y.; Reichl, U.; Thevenin, D.: Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 81 (8), p. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, September 08, 2009 - September 10, 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)

Noack, S.; Wahl, A.; Oldiges, M.; Wiechert, W.: Visualizing regulatory interactions in metabolic networks. In BMC Systems Biology, 1, p. 5. BioSysBio 2007 : Systems Biology, Bioinformatics and Synthetic Biology, Manchester, UK, January 11, 2007 - January 13, 2007. (2007)

Sidorenko, Y.; Dauner, M.; Genzel, Y.; Reichl, U.: Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, p. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, October 01, 2006 - October 05, 2006. (2006)

Sidorenko, Y.; Schulze-Horsel, J.; Voigt, A.; Reichl, U.; Kienle, A.: Stochastic Population Balance Modeling of Influenza Virus replication in a Vaccine Production Process. In Conference Proceedings / AIChE annual meeting 2006, p. 622f. AIChE annual meeting 2006, San Francisco, USA, November 12, 2006 - November 17, 2006. (2006)

Sidorenko, Y.; Reichl, U.: A Mathematical Model for the Replication of Influenza A Virus. In BioPerspective 2004: mit 22. DECHEMA-Jahrestagung der Biotechnologen: Kurzfassungen, p. 82. BioPerspective 2004 : mit 22. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany, May 04, 2004 - May 06, 2004. (2004)

Sidorenko, Y.; Reichl, U.: A Model for the Influenza Virus Live-Cycle in a Single Cell. In ICSB: 5th International Congress on Systems Biology: Book of abstracts, p. 382. ICSB : 5th International Congress on Systems Biology, Heidelberg, Germany, October 09, 2004 - October 13, 2004. (2004)

Möhler, L.; Flockerzi, D.; Reichl, U.: Mathematical Model of Virus Replication in Animal Cells. In Chemie Ingenieur Technik, 74 (5), pp. 661 - 662. GVC DECHEMA Jahrestagung, Wiesbaden, Germany, June 11, 2002 - June 13, 2002. (2002)

Trotha, R.; Reichl, U.; Koenig, W.; Koenig, B.: Validation of a T-RFLP Technique for the Precise Qualitative and Quantitative Characterization of Microbioal Communities by Using an Automated High Throughput Multi-Capillary Electrophoresis Device. In Abstracts of the General Meeting of the American Society for Microbiology, N-102, p. 323. 102nd General Meeting of the American Society for Microbiology, Salt Lake City, USA, May 19, 2002 - May 23, 2002. (2002)

Pelz, L.; Dogra, T.; Piasecka, J.; Rüdiger, D.; Bälkner, M.; Boehme, J.D.; Kershaw, O.; Volckmar, J.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo Efficacy. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Pelz, L.; Dogra, T.; Piasecka, J.; Rüdiger, D.; Bälkner, M.; Boehme, J.D.; Volckmar, J.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacy. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Expanding Glycoproteomics: Including N-Glycopeptides Bearing Glucuronidated, O-Acetylated or Sulfated N-Glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. GlycoBioTec 2025, Berlin (Germany) (2025)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 6^th MECP (Multistep Enzyme Catalyzed Processes) Congress, Vienna (Austria) (2024)

Genzel, Y.; Göbel, S.; Reichl, U.: Shaking to very high cell densities - perfusion for virus production. Kuhner Large Scale Meeting, Girona (Spain) (2024)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yield. 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI), Rio de Janeiro (Brazil) (2024)

Nguyen, R. T.: eversyn - Making high-value glycans mainstream. Sustainable Future Selection Day, Sunnyvale (USA) (2024)

Nguyen, R. T.: eversyn - Making high-value glycans mainstream. Sustainable Future Selection Day, San Francisco (USA) (2024)

Pelz, L.; Rüdiger, D.; Hein, M.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Engineered defective interfering particles of influenza A virus for antiviral treatment. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Pelz, L.; Rüdiger, D.; Hein, M. D.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Rexer, T.: Plattform for the in-vitro glycoengineering of proteins. 17th Annual European Life Sciences CEO Forum, Zurich (Switzerland) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systems. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissues. KSMB-SMB 2024, Seoul (South Korea) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Discovering Rare Sialylated N glycans Holding O Acetylation or Sulfation within the Site-Specific N glycosylation of Human Serum IgA. SialoGlyco 2024 (International Conference in SialoGlycobiology 2024), Lille (France) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Including N glycopeptides Bearing Glucuronidated, O Acetylated or Sulfated N glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. 33rd Joint Glycobiology Meeting (JGM) , Hannover (Germany) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Expanding Glycoproteomics: Including N‑glycopeptides Bearing Glucuronidated, O‑Acetylated or Sulfated N‑glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. EGC 2024 webinar (European Glycoscience Community Webinar Series), online (2024)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 3^rd Japan-Switzerland-Germany Workshop on Biocatalysis and Bioprocess Development , Aichi (Japan) (2023)

Dogra, T.; Pelz, L.; Boehme, J. D.; Baelkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17^th Vaccine Congress, Glasgow (Scotland) (2023)

Dogra, T.; Pelz, L.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. Vir-AI-DIP Workshop , Hamburg (Germany) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Exercise on vaccine design. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Intensification. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16^th PEACe Conference, Sitges (Spain) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)

Göbel, S.; Dallmeier, K.; Jordan, I.; de Jong, J.; Reichl, U.; Genzel, Y.: Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)